Isomorphic Labs, a company that uses AI to improve healthcare outcomes, is making a significant impact in the industry with its STAT+ technology. STAT+ is already being used in hospitals and clinics across the country and is expected to revolutionize the way healthcare is delivered. The company has also developed an AI tool for predicting heart attacks and is using its technology to identify the best treatment options for cancer patients. Isomorphic Labs is a company that is changing the healthcare landscape, and STAT+ subscribers will have access to exclusive insights and analysis on its technology and future plans.
Key points
Isomorphic Labs is making a big impact in the healthcare industry with its STAT+ technolo…: Isomorphic Labs is making a big impact in the healthcare industry with its STAT+ technology.
STAT+ is already being used in hospitals and clinics nationwide, poised to revolutionize…: STAT+ is already being used in hospitals and clinics nationwide, poised to revolutionize healthcare delivery.
Isomorphic Labs has developed an AI tool for predicting heart attacks, further enhancing…: Isomorphic Labs has developed an AI tool for predicting heart attacks, further enhancing patient care.
Sources checked by our analysis pipeline: 1
This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.
Some of the best quotes from last week’s STAT Summit came from Roivant CEO Matt Gline, who mused on Dario Amodei’s idea that AI will cure all disease. He’s got a quote about how biotech is a “woodchipper built to ingest souls and shred them” and another on how Amodei will find that no one wants to “go to an AI restaurant and eat an AI cheeseburger.”
For more context, watch his (and all STAT Summit sessions) on-demand here. Protip: The STAT subscriber 40% off code still works on this, too!
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Meta Platforms Inc. has revised its 2026 capex forecast to $135B-$145B, up from $130B-$145B, and its Q4 revenue forecast to $73B-$76B, up from $73.6B. The company's stock price has surged by 3%+ after hours following the announcement.
New York's inaugural microdrama film festival, Alza, aimed to legitimize vertical entertainment as an art form but left its audience uncertain about the future of this genre. The festival showcased a variety of short and vertical content, including adaptations of classic novels and romantic dramas, with a primary focus on appealing to mainstream women who watch microdramas on their phones. While some microdramas have been successful, the festival's attendees seemed skeptical about the future of vertical entertainm…
Anthropic, a tech company, has launched Claude Duet, an AI agent app aimed at improving productivity and efficiency. This app is part of Anthropic's suite and is expected to streamline tasks for users.